Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.
Hallberg P, Persson M, Axelsson T, Cavalli M, Norling P, Johansson HE, Yue QY, Magnusson PK, Wadelius C, Eriksson N, Wadelius M. Hallberg P, et al. Among authors: wadelius m, wadelius c. Pharmacogenomics. 2017 Feb;18(3):201-213. doi: 10.2217/pgs-2016-0184. Epub 2017 Jan 13. Pharmacogenomics. 2017. PMID: 28084903
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
Rasmussen ER, Hallberg P, Baranova EV, Eriksson N, Karawajczyk M, Johansson C, Cavalli M, Maroteau C, Veluchamy A, Islander G, Hugosson S, Terreehorst I, Asselbergs FW, Norling P, Johansson HE, Kohnke H, Syvänen AC, Siddiqui MK, Lang CC, Magnusson PKE, Yue QY, Wadelius C, von Buchwald C, Bygum A, Alfirevic A, Maitland-van der Zee AH, Palmer CNA, Wadelius M. Rasmussen ER, et al. Among authors: wadelius m, wadelius c. Pharmacogenomics J. 2020 Dec;20(6):770-783. doi: 10.1038/s41397-020-0165-2. Epub 2020 Feb 21. Pharmacogenomics J. 2020. PMID: 32080354 Free PMC article.
Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy.
Eriksson N, Wallentin L, Berglund L, Axelsson T, Connolly S, Eikelboom J, Ezekowitz M, Oldgren J, Paré G, Reilly P, Siegbahn A, Syvanen AC, Wadelius C, Yusuf S, Wadelius M. Eriksson N, et al. Among authors: wadelius m, wadelius c. Pharmacogenomics. 2016 Aug;17(13):1425-39. doi: 10.2217/pgs-2016-0061. Epub 2016 Aug 4. Pharmacogenomics. 2016. PMID: 27488176
Common VKORC1 and GGCX polymorphisms associated with warfarin dose.
Wadelius M, Chen LY, Downes K, Ghori J, Hunt S, Eriksson N, Wallerman O, Melhus H, Wadelius C, Bentley D, Deloukas P. Wadelius M, et al. Among authors: wadelius c. Pharmacogenomics J. 2005;5(4):262-70. doi: 10.1038/sj.tpj.6500313. Pharmacogenomics J. 2005. PMID: 15883587
183 results